Clinical needs for hematopoietic growth factors: old and new

Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999

The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma.

European journal of cancer (Oxford, England : 1990)·1998

The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·1998

Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997

Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint.

International journal of antimicrobial agents·1997

Are quality of life, patient preferences, and costs realistic outcomes for clinical trials?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·1997

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Cancer investigation·2026

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Cancer investigation·2026

Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.

Cancer investigation·2026

Measurement Properties of the Brazilian-Portuguese Version of Memorial Symptom Assessment Scale in Hospitalized Patients Undergoing Chemotherapy: A Longitudinal Study.

Cancer investigation·2026

Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Cancer investigation·2026

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Cancer investigation·2026

Vaso-occlusive crisis in the cervicofacial region in sickle cell anemia.

Journal of the American Dental Association (1939)·2026

Mechanisms of Liancao Xueniao Capsules in Treating Hematuria Associated with IgA Nephropathy: Network Pharmacology and Experimental Validation.

Journal of visualized experiments : JoVE·2026

Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis.

Molecular therapy. Nucleic acids·2026

Prognostic role of monocyte-to-high-density lipoprotein ratio in mortality of VTE patients at Ardabil (2023-2024).

Caspian journal of internal medicine·2026

Flatline Thromboelastography During Massive Intraoperative Bleeding in a Patient With Multiple Myeloma: A Case Report.

Cureus·2026

Early antiplatelet therapy was associated with reduced neurological deterioration in stroke patients treated with intravenous thrombolysis.

Brain circulation·2026

Related Experiment Videos

Clinical needs for hematopoietic growth factors: old and new

Related Concept Videos

Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group.

The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma.

The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy.

Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group.

Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint.

Are quality of life, patient preferences, and costs realistic outcomes for clinical trials?

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.

Measurement Properties of the Brazilian-Portuguese Version of Memorial Symptom Assessment Scale in Hospitalized Patients Undergoing Chemotherapy: A Longitudinal Study.

Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Vaso-occlusive crisis in the cervicofacial region in sickle cell anemia.

Mechanisms of Liancao Xueniao Capsules in Treating Hematuria Associated with IgA Nephropathy: Network Pharmacology and Experimental Validation.

Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis.

Prognostic role of monocyte-to-high-density lipoprotein ratio in mortality of VTE patients at Ardabil (2023-2024).

Flatline Thromboelastography During Massive Intraoperative Bleeding in a Patient With Multiple Myeloma: A Case Report.

Early antiplatelet therapy was associated with reduced neurological deterioration in stroke patients treated with intravenous thrombolysis.

Related Experiment Videos

Clinical needs for hematopoietic growth factors: old and new

Related Concept Videos

Related Articles